KPMA opposes incentive for low-priced drugs

The government's plan to pass a bill aiming at introducing the controversial incentive system for medical institution's low-priced drug purchase in the National Assembly may further promote unfair transactions via behind-the-scene contracts between hospitals and drug makers in the presence of hospital's opaque management accounting, according to the Korea Pharmaceutical Manufacturers Associatio...